Exam 3; SE and Treatments Flashcards
SE: agranulocytosis
ticlopidine (ADP receptor blocker)
SE: anorexia
quinidine (Na+ channel blocker)
SE: anti-DUMBBELS (anti-muscarinic)
disopyramide (Na+ channel blocker)
SE: anti-vagal effects (2)
quinidine, disopyramide (Na+ channel blockers)
SE: asthma
“olol”s (Class II beta blockers)
SE: bradycardia
“olol”s (Class II beta blockers)
SE: bleeding/hemorrhage (3)
heparin (activates antithrombin)
warfarin (inhibits enzyme)
dabigatran (inhibits thrombin)
SE: bleeding after spinal tap/surgery
rivaroxaban, apixaban (inhibits factor Xa)
SE: intra-cranial bleeding
vorapaxar (thrombin receptor blocker)
SE: prolong bleeding time
thrombolytic agents (convert plasminogen --> plasmin) ie streptokinase, urokinase, TPA
SE: toxic effects on conductive tissues
digoxin (inhibits Na-K-ATPase)
SE: optic neuritic
amidorone (K+ channel blocker)
SE: cutaneous flusing
niacin (inhibits enzyme, may bind a receptor –> block VLDL synthesis)
SE: skin flushing
nitrates (activate guanylate cyclase enzyme)
SE: diabetes
niacin (inhibits enzyme, may bind a receptor –> block VLDL synthesis)
SE: inc uric acid –> gout
niacin (inhibits enzyme, may bind a receptor –> block VLDL synthesis)
SE: hallucinations
digoxin (inhibits Na-K-ATPase)
SE: HIT (loss of platelets)
heparin (activates antithrombin)
SE: hypotension (2)
GTN (activate guanylate cyclase enzyme)
“olol”s (CLass II beta blockers)
SE: itching
niacin (inhibits enzyme, may bind a receptor –> block VLDL synthesis)
SE: iodine deposits
amidorone (K+ channel blocker)
SE: liver damage (3)
amiodarone (K+ channel blocker - all four)
“statin”s (inhibit HMG-CoA reductase enzyme)
lomitapide (inhibits assembly of VLDL –> hepatotoxicity)
SE: lupus-like syndrome
procainamide (Na+ channel blockers)
SE: myocardial infarction
“afils” (inhibit Type 5 cGMP phosphodiesterase enzyme)
SE: myositis –> rhabomyolsis
“statin”s (inhibit HMG-CoA reductase enzyme)